Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Atzpodien

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
Cytokine|July 1, 1994
Soluble interleukin 2 receptors abrogate IL-2 induced activation of peripheral mononuclear cellsU Zorn, I Dallmann, J Grosse, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancerJ Atzpodien, H Kirchner, E L Hänninen, et al.
European Journal of Haematology. Supplementum|January 1, 1989
Ex vivo treatment of myeloma cells by 4-HC, VP-16, LAK cells and antibodiesS C Gulati, C Shimazaki, R M Lemoli, et al.
The Journal of Urology|July 20, 2002
Primary apoptosis as a prognostic index for the classification of metastatic renal cell carcinomaE N Richter, K Oevermann, N Buentig, et al.
The British Journal of Dermatology|April 1, 1993
Molecular detection of clone-specific DNA in hypopigmented lesions of a patient with early evolving mycosis fungoidesM Volkenandt, H P Soyer, L Cerroni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-alphaJ Atzpodien, A Körfer, P A Palmer, et al.
Journal of Cancer Research and Clinical Oncology|October 12, 2012
A nine-gene signature predicting clinical outcome in cutaneous melanomaG Brunner, M Reitz, A Heinecke, et al.
Blood|August 1, 1990
Establishment and characterization of a granulocyte-macrophage colony-stimulating factor-dependent human myeloid cell lineS Oez, H Tittelbach, R Fahsold, et al.
Anticancer Research|June 12, 1999
Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastineN Meyer, S Duensing, G Anastassiou, et al.
Thyroid : Official Journal of the American Thyroid Association|February 12, 1998
Patients treated with interferon-alpha, interferon-beta, and interleukin-2 have a different thyroid autoantibody pattern than patients suffering from endogenous autoimmune thyroid diseaseF Schuppert, E Rambusch, H Kirchner, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Cytokine|July 1, 1994
Soluble interleukin 2 receptors abrogate IL-2 induced activation of peripheral mononuclear cellsU Zorn, I Dallmann, J Grosse, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancerJ Atzpodien, H Kirchner, E L Hänninen, et al.
European Journal of Haematology. Supplementum|January 1, 1989
Ex vivo treatment of myeloma cells by 4-HC, VP-16, LAK cells and antibodiesS C Gulati, C Shimazaki, R M Lemoli, et al.
The Journal of Urology|July 20, 2002
Primary apoptosis as a prognostic index for the classification of metastatic renal cell carcinomaE N Richter, K Oevermann, N Buentig, et al.
The British Journal of Dermatology|April 1, 1993
Molecular detection of clone-specific DNA in hypopigmented lesions of a patient with early evolving mycosis fungoidesM Volkenandt, H P Soyer, L Cerroni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-alphaJ Atzpodien, A Körfer, P A Palmer, et al.
Journal of Cancer Research and Clinical Oncology|October 12, 2012
A nine-gene signature predicting clinical outcome in cutaneous melanomaG Brunner, M Reitz, A Heinecke, et al.
Blood|August 1, 1990
Establishment and characterization of a granulocyte-macrophage colony-stimulating factor-dependent human myeloid cell lineS Oez, H Tittelbach, R Fahsold, et al.
Anticancer Research|June 12, 1999
Altered expression of beta 1 integrins in renal carcinoma cell lines exposed to vinblastineN Meyer, S Duensing, G Anastassiou, et al.
Thyroid : Official Journal of the American Thyroid Association|February 12, 1998
Patients treated with interferon-alpha, interferon-beta, and interleukin-2 have a different thyroid autoantibody pattern than patients suffering from endogenous autoimmune thyroid diseaseF Schuppert, E Rambusch, H Kirchner, et al.
Pageof 12